Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Lupus nephritis: lessons from murine models.

Anne Davidson1, Cynthia Aranow

  • 1Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA. adavidson1@nshs.edu

Nature Reviews. Rheumatology
|December 2, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

An efficient approach to study ANA⁺ B cells in autoimmune diseases integrating flow cytometry with single-cell analysis.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis.

bioRxiv : the preprint server for biology·2026
Same author

Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis.

Kidney international·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026

Current lupus nephritis treatments are ineffective, leading to rising end-stage renal disease. New therapeutic strategies are needed to manage this autoimmune kidney disease, focusing on early intervention and organ protection.

Area of Science:

  • Immunology
  • Nephrology
  • Rheumatology

Background:

  • Lupus nephritis presents significant therapeutic challenges, with current treatments often failing to induce remission or causing adverse effects.
  • Despite advances in understanding immune pathways, effective new treatments for lupus nephritis remain elusive, and end-stage renal disease rates are increasing.
  • Established lupus nephritis is difficult to reverse by targeting single pathways due to complex immune networks and long-lived autoreactive cells.

Purpose of the Study:

  • To analyze the mechanisms of action of novel immunomodulatory drugs in murine lupus models.
  • To identify key immune and inflammatory pathways involved in lupus nephritis progression.
  • To propose new management paradigms for systemic lupus erythematosus based on preclinical data.

Main Methods:

More Related Videos

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Related Experiment Videos

Last Updated: Jun 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

  • Analysis of immunomodulatory drug mechanisms in multiple murine lupus models.
  • Investigation of immune activation and effector inflammatory pathways.
  • Review of data from preclinical lupus models.

Main Results:

  • Complex interacting networks of immune and effector pathways are activated as lupus nephritis progresses.
  • Targeting single cell populations or inflammatory pathways is insufficient to reverse established disease.
  • Murine models indicate the need for earlier immune intervention and long-term maintenance therapies.

Conclusions:

  • Current lupus nephritis therapies are inadequate for remission induction and managing toxicity.
  • New management strategies for systemic lupus erythematosus should incorporate early intervention, maintenance therapy, and organ protection.
  • Understanding complex immune networks is crucial for developing effective treatments for lupus nephritis.